Joel Greenblatt's BMRN Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 174,091 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $9.83 M, representing 0.03% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in BMRN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 145,886 shares. Largest reduction occurred in Q1 2026, reducing 95,420 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -95,420 | Reduce 35.40% | 174,091 | $56.49 |
| Q4 2025 | +4,179 | Add 1.58% | 269,511 | $59.43 |
| Q3 2025 | +145,886 | Add 122.14% | 265,332 | $54.16 |
| Q2 2025 | +71,977 | Add 151.63% | 119,446 | $54.97 |
| Q1 2025 | +35,735 | Add 304.54% | 47,469 | $70.69 |
| Q4 2024 | -11,661 | Reduce 49.84% | 11,734 | $65.73 |
| Q3 2024 | +23,395 | New Buy | 23,395 | $70.29 |
| Q1 2024 | -2,446 | Sold Out | 0 | $0.00 |
| Q4 2023 | -1,610 | Reduce 39.69% | 2,446 | $96.42 |
| Q3 2023 | +4,056 | New Buy | 4,056 | $88.48 |
| Q2 2023 | -3,758 | Sold Out | 0 | $0.00 |
| Q1 2023 | +3,758 | New Buy | 3,758 | $97.24 |
| Q4 2021 | -3,241 | Sold Out | 0 | $0.00 |
| Q3 2021 | +3,241 | New Buy | 3,241 | $77.14 |
| Q3 2020 | -5,842 | Sold Out | 0 | $0.00 |
| Q2 2020 | -5,178 | Reduce 46.99% | 5,842 | $123.42 |
| Q1 2020 | +2,860 | Add 35.05% | 11,020 | $84.48 |
| Q4 2019 | +8,160 | New Buy | 8,160 | $84.56 |
| Q4 2017 | -3,590 | Sold Out | 0 | $0.00 |
| Q3 2017 | +3,590 | New Buy | 3,590 | $93.04 |
| Q3 2016 | -3,144 | Sold Out | 0 | $0.00 |
| Q2 2016 | +3,144 | New Buy | 3,144 | $77.93 |
| Q2 2015 | -4,195 | Sold Out | 0 | $0.00 |
| Q1 2015 | +4,195 | New Buy | 4,195 | $124.67 |
| Q4 2014 | -3,885 | Sold Out | 0 | $0.00 |
| Q3 2014 | +3,885 | New Buy | 3,885 | $72.07 |
Joel Greenblatt's BioMarin Pharmaceutical Investment FAQs
Joel Greenblatt first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q3 2014, acquiring 3,885 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held BioMarin Pharmaceutical Inc. (BMRN) for 26 quarters since Q3 2014.
Joel Greenblatt's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q3 2025, adding 265,332 shares worth $14.37 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 174,091 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $9.83 M.
As of the Q1 2026 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.03% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 269,511 shares, as reported at the end of Q4 2025.